On Invalid Date, Forte Biosciences (NASDAQ: FBRX) reported Q3 2022 earnings per share (EPS) of -$0.18, up 66.67% year over year. Total Forte Biosciences earnings for the quarter were -$3.40 million. In the same quarter last year, Forte Biosciences's earnings per share (EPS) was -$0.54.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.